Search Orphan Drug Designations and Approvals
-
Generic Name: | O-(2-[18F]fluoroethyl)-L-tyrosine |
---|---|
Date Designated: | 10/05/2020 |
Orphan Designation: | Diagnostic for the management of glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Telix Pharmaceuticals Limited (Telix) 55 Flemington Road Suite 401 North Melbourne, Victoria 3015 Australia The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-